EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug Repurposing to Inhibit Histamine N-Methyl Transferase

Elvia Mera Jiménez, Teresa Żołek iD, Paola Gabriela Hernández Perez, Rene Miranda Ruvalcaba iD, María Inés Nicolás-Vázquez, Maricarmen Hernández-Rodríguez iD

Molecules · 2023

DOI: 10.3390/molecules28020576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Elvia Mera Jiménez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Cultivo Celular, Sección de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Salvador Díaz Miró…. Hauptthemen laut MEDLINE: Histamine, Transferases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Instituto Politécnico Nacional, National Autonomous University of Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lower activity of the histaminergic system is associated with neurological disorders, including Alzheimer’s disease (AD). Thus, the enhancement of histaminergic neurotransmission by inhibition of histamine N-methyl transferase (HNMT), which degrades histamine, appears as an important approach. For this purpose, rigid and flexible molecular docking studies of 185 FDA-approved drugs with the HNMT enzyme were carried out to select two compounds to perform molecular dynamics (MD) simulations to evaluate the binding free energies and stability of the enzyme–drug complexes. Finally, an HNMT inhibition assay was performed to corroborate their effect towards HNMT. Molecular docking studies with HNMT allowed the selection of dihydroergotamine and vilazodone since these molecules showed the lowest Gibbs free energy values. Analysis of the binding mode of vilazodone showed interactions with the binding pocket of HNMT with Glu28, Gln143, and Asn283. In contrast, dihydroergotamine binds to the HNMT active site in a different location, apparently because it is overall the more rigid ligand compared to flexible vilazodone. HNMT inhibitory activity for dihydroergotamine and vilazodone was corroborated (IC50 = 72.89 μM and 45.01 μM, respectively) by in vitro assays. Drug repurposing of HNMT was achieved by employing computational studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistamineTransferasesHistamine N-MethyltransferaseVilazodone HydrochlorideMolecular Docking SimulationDrug RepositioningDihydroergotamine

Stichwörter der Autor:innen

computational studiesdrug repurposinghistamine N-methyl transferasemolecular docking studiesmolecular dynamics simulations

Substanzen

HistamineTransferasesHistamine N-MethyltransferaseVilazodone HydrochlorideDihydroergotamine

Autor:innen und Institutionen

  • Laboratorio de Cultivo Celular, Sección de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Salvador Díaz Mirón Esq. Plan de San Luis s/n, Casco de Santo Tomas, Miguel Hidalgo, Mex…
  • Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-091 Warsaw, Poland.
  • Química Inorgánica-Orgánica del Departamento de Ciencias Químicas, Facultad de Estudios Superiores Cuautitlán Campo 1, UNAM. Av. Primero de Mayo S/N, Sta María Guadalupe las Torres, Cuautitlán Izcalli 54740, Mexico.

ORCID-Profile: Teresa Żołek, Rene Miranda Ruvalcaba, Maricarmen Hernández-Rodríguez

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • Instituto Politécnico Nacional
  • National Autonomous University of Mexico
  • Consejo Nacional de Ciencia y Tecnologia (CONACyT)
  • PAPIIT-UNAM

Zitieren

APA

Jiménez, E. M., Żołek, T., Hernández Perez, P. G., Miranda Ruvalcaba, R., Nicolás-Vázquez, M. I., & Hernández-Rodríguez, M. (2023). Drug Repurposing to Inhibit Histamine N-Methyl Transferase. Molecules. https://doi.org/10.3390/molecules28020576

Vancouver

Jiménez EM, Żołek T, Hernández Perez PG, Miranda Ruvalcaba R, Nicolás-Vázquez MI, Hernández-Rodríguez M. Drug Repurposing to Inhibit Histamine N-Methyl Transferase. Molecules. 2023. doi:10.3390/molecules28020576

BibTeX
@article{Jimnez2023,
  author = {Jiménez, Elvia Mera and Żołek, Teresa and Hernández Perez, Paola Gabriela and Miranda Ruvalcaba, Rene and Nicolás-Vázquez, María Inés and Hernández-Rodríguez, Maricarmen},
  title = {Drug Repurposing to Inhibit Histamine N-Methyl Transferase},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020576}
}
Kostenlos starten →